-
21-05-2023, 10:15 PM
#531
Originally Posted by RRR
If they do that, will be anti-competitive and they will be sued if they do that!
GXH pharmacy business is growing again - chemist warehouse were supposed to decimate their pharmacy business - didn't happen..GXH is now stronger than ever..
Kiwical - $5 is significant money for many..$5 is per medication - if several medications are prescribed expense adds up to a significant amount..just imagine the situation for patient who are on these medications long term. Prescriptions are now dispensed every month - previously they used to dispense 3 months supply..
GXH dont get the $5 fee - but the likes of CWH were waiving the $5 fee which were leading to loss of customers for pharmacies owned by GXH
Doubt it. If Chemist Warehouse advertised a "free" voucher with every prescription there is no element of anti-competitive behaviour. Quite the opposite.
-
21-05-2023, 10:22 PM
#532
CWH might have rename their Free $5 Giveaway, if they intend continuing dishing it out
-
21-11-2023, 09:13 PM
#533
Holy **** .. Man jump overboard reported in Sep 2023
https://www.nzx.com/announcements/417925
CFO wave final good byes in December
Backpedal to Feb 2023 -
Green Cross Health sold Access Community Health division to Anchorage Capital Partners on 28 February 2023.
Time yet to start selling some more bits or whole kaboddle for another large divie .. or too soon ?
Must be time to roll out the next bundle of 2023 reports soon
Last edited by nztx; 21-11-2023 at 09:33 PM.
-
29-11-2023, 09:03 AM
#534
https://www.nzx.com/announcements/422576
Result Summary:
Operating Revenue of $250m, up 1%
Operating Profit (EBIT) of $14.9m, down 17% due to reduced higher-margin COVID-19 activity
Net Profit After Tax Attributable to Shareholders of $5.6m, down 21%1
Pharmacy Operating Revenue up 1% and Operating Profit down 25% to $8.7m
Medical Operating Revenue up 1% and Operating Profit down 21% to $7.3m
Investment in growth of $7.9m in three new medical centres and eight site refurbishments; two further medical centres acquired post interim balance date
2.5cps interim dividend declared, to be paid on 20 December 2023.
-
11-12-2023, 09:47 PM
#535
https://www.nzherald.co.nz/business/...JNXVAJ6CSKAHAY
Chemist Warehouse to merge with Aussie company in $750m proposal
Chemist Warehouse will merge with a big Australian company and create a new entity worth almost $10 billion under a proposed deal.
Melbourne-based Sigma Healthcare today said it wanted to merge with the aggressive pharmaceutical retailer.
But the deal will need to win approval from watchdogs including the Overseas Investment Office.
Chemist Warehouse has hundreds of stores across Australia and New Zealand, with an estimated 600 in Australia alone.
Sigma Healthcare’s retail brands include Amcal+ and it also has aged care services.
Sigma aims to seal the deal with $752m cash and Sigma shares.
The Competition just expressed it's desire to morph into a larger Gorilla
-
02-05-2024, 12:26 AM
#536
-
30-05-2024, 08:49 AM
#537
”When investors are euphoric, they are incapable of recognising euphoria itself “
-
30-05-2024, 08:52 AM
#538
Originally Posted by winner69
I thought it was a very poor result.
Result Summary
•Operating Revenue1 of $503.9m, up 2%
•Operating Profit (EBIT)1 of $31.8m, down 7% due to inflationary pressures, lower retail spending and reduced higher margin COVID-19 activity
•Net Profit After Tax Attributable to Shareholders1 down 20% to $12.0m
•Pharmacy Operating Revenue up 1% and Operating Profit down 8% to $19.3m
•Medical Operating Revenue up 5% and Operating Profit down 8% to $15.0m
•Investment in growth of $17.9m, including seven new medical centres and one pharmacy
•2.0cps dividend declared, to be paid on 21 June 2024.
-
30-05-2024, 12:31 PM
#539
Originally Posted by percy
I thought it was a very poor result.
Result Summary
•Operating Revenue1 of $503.9m, up 2%
•Operating Profit (EBIT)1 of $31.8m, down 7% due to inflationary pressures, lower retail spending and reduced higher margin COVID-19 activity
•Net Profit After Tax Attributable to Shareholders1 down 20% to $12.0m
•Pharmacy Operating Revenue up 1% and Operating Profit down 8% to $19.3m
•Medical Operating Revenue up 5% and Operating Profit down 8% to $15.0m
•Investment in growth of $17.9m, including seven new medical centres and one pharmacy
•2.0cps dividend declared, to be paid on 21 June 2024.
Agree Percy .. T/over up and other metrics going backwards including profit and NPAT.
Looks like a huge expenses or Margin hit somewhere ?
The Dividend trend after the 28c Special in Apr 2023, from hocking off some Crystal jewels appears to be retrenching.
What the next period will show could be anyone's guess in a recessionary environment, in a goldfish bowl with other large predators and potentially another large Covid wave on us right now ..
Last edited by nztx; 30-05-2024 at 12:33 PM.
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks